Авторы

  • Закирьяева П.О., Исмаилов Ж.А.

Ключевые слова:

неспецифическая интерстициальная пневмония, фиброз лёгких, глюко-кортикостероиды, иммуносупрессия, Лонгидаза, гиалуронидаза.

Библиографические ссылки

Travis W.D. et al. ATS/ERS Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–748.

Flaherty K.R., Wells A.U. Non-specific interstitial pneumonia: current approach to diagnosis and management. Clin Chest Med. 2021;42(3):329–343.

Kolb M., Vašáková M. The natural history of progressive fibrosing interstitial lung diseases. Respir Res. 2019;20:57.

Distler O. et al. Targeting immune and fibrotic pathways in interstitial lung diseases. Eur Respir Rev. 2022;31(165):210278.

Инструкция по медицинскому применению препарата Лонгидаза®. Министерство здравоохранения РФ, 2023.

Frantz R. P. et al. Baseline and serial brain natriuretic peptide level predicts 5-year overall survival in patients with pulmonary arterial hypertension: data from the REVEAL registry //Chest. – 2018. – Т. 154. – №. 1. – С. 126-135.

Graney B. A., Fischer A. Interstitial pneumonia with autoimmune features //Annals of the American Thoracic Society. – 2019. – Т. 16. – №. 5. – С. 525-533.

Groth A, Vrugt B, Brock M, Speich R, Ulrich S, Huber LC. Inflammatory cytokines in pulmonary hypertension. Respir Res 2014;15:47. [PMC free article] [PubMed] [Google Scholar],

Hellemons M. E. et al. Desquamative interstitial pneumonia: a systematic review of its features and outcomes //European Respiratory Review. – 2020. – Т. 29. – №. 156.

Hendriks P. M. et al. Прогностическое значение мозговых натрийуретических пептидов у пациентов с легочной артериальной гипертензией: систематический обзор и мета-анализ //Американский кардиологический журнал. – 2022. – Т. 250. – С. 34-44.

Hino T, Lee KS, Yoo H, Han J, Franks TJ, Hatabu H. Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP). Eur J Radiol Open. 2021 Mar 16;8:100336. doi: 10.1016/j.ejro.20 21.100336. PMID: 33796637; PMCID: PMC7995484.

Holbrook J. et al. Tumour necrosis factor signalling in health and disease //F1000Research. – 2019. – Т. 8. – С. F1000 Faculty Rev-111.

https://pmc.ncbi.nlm.nih.gov/articles/PMC2700448, https://studfile.net/preview/21494193 /page:195/

https://pmc.ncbi.nlm.nih.gov/articles/PMC4236489/

https://radiopaedia.org/articles/nonspecific-interstitial-pneumonia-1 https://scholar.google. com/citations?view_op=view_citation&hl=ru&user=4Y0iQcIAAAAJ&citation_for_view=4Y0iQcIAAAAJ:J_g5lzvAfSwC

https://www.sammu.uz/uz/article/794/download

Huaux F. Interpreting immunoregulation in lung fibrosis: a new branch of the immune model //Frontiers in Immunology. – 2021. – Т. 12. – С. 690375.

Januszkiewicz A. Przekształcenia form architektury świątyni wskutek zmiany konfesj–na przykładzie kościoła rzymskokatolickiego pw. Nie-pokalanego Poczęcia Najświętszej Maryi Panny w Lublinie. – 2017..

Jo Y. S. et al. Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial Pneumonia // Tuberculosis and Respiratory Diseases. – 2025. – Т. 88. – №. 2. – С. 237.

Joyce Lee, MD, MAS, University of Colorado School of Medicine https://www.msdmanuals.com /ru.

Kacprzak A., Tomkowski W., Szturmowicz M. Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy //Diagnostics. – 2023. – Т. 13. – №. 14. – С. 2354.

Karhu J. et al. Interleukin-5, interleukin-6, interferon induced protein-10, procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients //Cytokine. – 2019. – Т. 113. – С. 272-276.

Kass D. J. et al. Comparative profiling of serum protein biomarkers in rheumatoid arthritis–associated interstitial lung disease and idiopathic pulmonary fibrosis //Arthritis & Rheumatology. – 2020. – Т. 72. – №. 3. – С. 409-419.

Komatsu M. et al. Clinical characteristics of immunoglobulin G4-positive interstitial pneumonia //ERJ Open Research. – 2021. – Т. 7. – №. 3.

Kono M. et al. Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease //Respiratory medicine. – 2016. – Т. 117. – С. 40-47.

Kowalski B. et al. Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: A cross-sectional case–control study //Journal of cancer research and clinical oncology. – 2022. – Т. 148. – №. 7. – С. 1711-1720.

Lee J, Kim YH, Kang JY, Jegal Y, Park SY; Korean Interstitial Lung Diseases Study Group. Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia. Tuberc Respir Dis (Seoul). 2019 Oct;82(4):277-284. doi: 10.4046/trd.2018.00 92. Epub 2019 May 31. PMID: 31172700; PMCID: PMC6778744.

Lee S. H. et al. Korean guidelines for diagnosis and management of interstitial lung diseases: Part 2. Idiopathic pulmonary fibrosis //Tuberculosis and Respiratory Diseases. – 2019. – Т. 82. – №. 2. – С. 102-117.

Liu B., Chang X., Yan N. Clinical analysis of the epidemiology and changes in inflammatory indexes of Mycoplasma pneumonia in acute and recovery stage pediatric patients //Translational Pediatrics. – 2022. – Т. 11. – №. 10. – С. 1645.

Luppi F. et al. The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases //BMC pulmonary medicine. – 2023. – Т. 23. – №. 1. – С. 501..

Miądlikowska E. et al. Serum biomarkers of lung fibrosis in interstitial pneumonia with autoimmune features—what do we already know? //Journal of Clinical Medicine. – 2021. – Т. 11. – №. 1. – С. 79.

Miądlikowska E. et al. Serum biomarkers of lung fibrosis in interstitial pneumonia with autoimmune features—what do we already know? //Journal of Clinical Medicine. – 2021. – Т. 11. – №. 1. – С. 79.

Mortazavi S., de Peralta-Venturina M., Marchevsky A. M. Nonspecific interstitial pneumonia pattern is a frequent finding in patients with post-acute COVID-19 syndrome treated with bilateral orthotopic lung transplantation: current best evidence //Human Pathology. – 2023. – Т. 141. – С. 90-101.

Nathan S. D. et al. Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study //The Lancet Respiratory Medicine. – 2019. – Т. 7. – №. 9. – С. 780-790.

Nayfeh A. S., Chippa V., Moore D. R. Nonspecific interstitial pneumonitis. – 2018.

NN X. M. B. M. N. N. M., Zakiryayeva P. O., Nosirova D. E. Opka kasalliklari bilan bemorlarni olib borish //O’quv qo’llanma. Toshkent. – 2021. – С. 70-96.

Novel classification of idiopathic interstitial pneumonias: statement of American Thoracic Society / European Respiratory Society. PULMONO-LOGIYA. 2013;(5):9-24. published in the Manual edited by akad.RAS A.G.Chuchalina, 2024 Vol. 1-5

Neuper T. et al. IL-31 трансгенные мыши демонстрируют снижение аллерген-индуцированного воспаления легких //European Journal of Immunology. – 2021. – Т. 51. – No 1. – С. 191-196.Oliveira DS, Araújo Filho JA, Paiva AFL, Ikari ES, Chate RC, Nomura CH. Idiopathic interstitial pneumonias: review of the latest American Thoracic Society/European Respiratory Society classification. Radiol Bras. 2018 Sep-Oct;51(5):321-327. doi: 10.1590 /0100-3984.2016.0134. PMID: 30369660; PMCID: PMC6198836.

Ovcharenko S. I., Son E. A., Kapustina V. A. Multidisciplinary approach in the diagnosis of idiopathic nonspecific interstitial pneumonia //Terapevticheskii arkhiv. – 2019. – Т. 91. – №. 3. – С. 101-106.

Ponomareva L. A. et al. Methotrexate-induced lung damage in a patient with rheumatoid arthritis //Terapevticheskii arkhiv. – 2021. – Т. 93. – №. 3. – С. 295-299.

Renzoni E. A., Poletti V., Mackintosh J. A. Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia? //The Lancet. – 2021. – Т. 398. – №. 10309. – С. 1437-1449.

S. Kolahian, Isis E. Fernandez, O.Eickelberg, D. Hartl. Immune Mechanisms in Pulmonary Fibrosis//https://doi.org/10.1165/rcmb.2016-0121TR.

Schulze AB, Evers G, Kümmel A, Rosenow F, Sackarnd J, Hering JP, Schülke C, Engelbertz JA, Görlich D, Barth PJ, Lenz G, Becker H, Mohr M, Schmidt LH. Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases.

Sarcoidosis Vasc Diffuse Lung Dis. 2019; 36(2): 157-166. doi: 10.36141/svdld.v36i2.7636. Epub 2019 May 1. PMID: 32476949; PMCID: PMC72 47101.

Teoh A. K. Y., Corte T. J. Nonspecific interstitial pneumonia //Seminars in respiratory and critical care medicine. – Thieme Medical Publishers, 2020. – Т. 41. – №. 02. – С. 184-201.

The association between vascular endothelial growth factor (VEGF) +405G>C genetic polymorphism and endometriosis / F. Fang, L. Gong, X. Wang, L. Zhang // Exp. Biol. Med. (Maywood). – 2015. – Vol. 240, N 9. – P. 1177–1182..

Weerakkody Y, Campos A, Knipe H, et al. Non-specific interstitial pneumonia. Reference article, Radiopaedia.org (Accessed on 03 Feb 2025) https://doi.org/10.53347/rID-11007

Wijayaratne T., Owen J., Fahim A. Clinical behaviour and mortality in idiopathic vs secondary nonspecific interstitial pneumonia //Lung India. – 2024. – Т. 41. – №. 3. – С. 172-175.

Wijsenbeek M., Suzuki A., Maher T. M. Interstitial lung diseases //The Lancet. – 2022. – Т. 400. – №. 10354. – С. 769-786..

Wu R. et al. The Value of Serum Th1/Th2 Cytokines, PCT and CRP in Assessing the Severity and Prognosis of CAP Patients //Investigación Clínica. – 2020. – Т. 61. – №. 2. – С. 768-776.

Yamano Y. et al. Interstitial pneumonia with autoimmune features and histologic usual interstitial pneumonia treated with anti-fibrotic versus immunosuppressive therapy //Respiratory Investigation. – 2023. – Т. 61. – №. 3. – С. 297-305.

Yoon C. et al. Korean guidelines for diagnosis and management of interstitial lung diseases: part 3. Idiopathic nonspecific interstitial pneumonia //Tuberculosis and Respiratory Diseases. – 2019. – Т. 82. – №. 4. – С. 277-284..

Yu W, Guo F, Song X. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. Pharm Biol. 2017; 55 (1): 450-455..

Zhang Z. et al. Characterizing the lavage and serum cytokine profiles of interstitial pneumonia with autoimmune features and their implications for progressive fibrosis //Rheumatology. – 2024. – Т. 63. – №. 5. – С. 1230-1239.

Махматмурадова Наргиза Негматуллаевна, Ибадова Ольга Александровна, Закирьяева Парвина Адиловна дифференциальная диагностика неспецифической интерстициальной пневмонии // JCRR. 2020. №2. URL: https://cyberleninka.ru/article/n/differentsialnaya-diagnostika-nespetsificheskoy-interstitsialnoy-pnevmonii (дата обращения: 13.10.2025).

Закирьяева П. О. Влияние пульс-терапии с высокими дозами кортикостероидов на выживаемость пациентов с COVID-19 //Journal of cardiorespiratory research. – 2022. – Т. 3. – №. 2. – С. 47-55.

Aralov N. R. et al. Distinctive Features Of Non-Specific Interstitial Pneumonia //Биомедицина ва амалиёт журнали. – Т. 195.

Мамурова Н., Носирова Д., Закиряева П. Пневмонии с коморбидными течениями //Общество и инновации. – 2020. – Т. 1. – №. 1/S. – С. 651-655.